EIN Presswire: Investing Featured Press Releases

Independent Investor Announces Range Of Spread Betting And CFD Accounts

Wed, 08 Feb 2012 05:06:24 +0000

/EINPresswire.com/ Independent Investor is enabling spread betting traders across the board to find the most competitive brokerage deals from the market's leading suppliers, providing an unrivalled insight into the pricing, service levels and performance of the leading players in the world of financial spread betting to help ensure the best possible deal.

Online broker comparison and investment site IndependentInvestor.co.uk is helping spread betting and CFD traders source the best deal for their needs, factoring in a number of key criteria to provide at-a-glance, independent comparisons between the leading brokers on the market.

Alex Johnson, a spokesperson for IndependentInvestor.co.uk said that by using their direct, market leading spread comparisons, traders could quickly identify the best deals and simultaneously improve their chances of trading success by finding the best broker for their trading needs.

"Choosing a broker is in many respects like choosing a credit card, or browsing between different broadband providers - spread betting companies are not one and the same, and the difference in price and service can have a considerable effect on the bigger picture in terms of your trading performance. A slightly more expensive broker can turn into a real anchor on your performance when higher costs are multiplied by numerous transactions, while a broker with patchy market selection could be costing you trading opportunities. Depending on what you're looking for from your broker, it's critical to make sure you choose between different providers in order to find the most suitable package for you."

"At IndependentInvestor.co.uk, our sole aim is to make financial spread betting easier. We are traders ourselves, and we love what we do, but we understand just how confusing it can be. Even at the best of times, comparing brokers can be extremely difficult, and without access to a resource like ours making the right choice is a whole lot harder. That's why our easy comparisons make choosing a broker more straightforward."

In addition to the web's most in-depth, up-to-date broker reviews and comparisons, IndependentInvestor.co.uk is a free to use library of trading information and knowledge, across spread betting, CFDs, forex trading and share dealing amongst others, centred around helping traders become more successful in the markets.

Media Contact:
Alex Johnson
Independent Investor
07988819825
http://www.independentinvestor.co.uk

PR courtesy of Online PR Media: http://bit.ly/wMKZWO

FinancialSpreads Launches New FX Pricing

Wed, 08 Feb 2012 05:05:33 +0000

/EINPresswire.com/ Financial Spreads, has improved the way they price the FX markets in order to better reflect the underlying interbank market.

UK spread trading company, Financial Spreads, has improved the way they price the FX markets in order to better reflect the underlying interbank market. The company has added an extra decimal place to their FX prices.

The reason for doing this is to make the FX spread betting pricing more precise and therefore give account holders a better and more accurate price to trade on.

How Does this Work?

The Financial Spreads FX markets are now shown down to an extra decimal place. This has not changed the point size of the market but simply provides an extra layer of accuracy.

For example, on EUR/USD, the size of a point is still $0.0001 = $0.00010. However, when calculating the result of a trade the extra decimal place is considered as a fraction of a point.

In the past, for EUR/USD, Financial Spreads rounded the tradable values to the fourth decimal place so a short-term long-trade might have worked as:

Point Size: $0.0001
Stake: £5 per point
Buy Price: $1.3100
Sell Price: $1.3120
Price Difference: ($1.3120 - $1.3100) = $0.0020 = 20 points
Profit / Loss: 20 points x stake = 20 points x £5 per point = £100.00

Under the new system the trade is more accurately rounded to the fifth decimal place and so the same trade might actually be:

Point Size: $0.00010
Stake: £5 per point
Buy Price: $1.30998
Sell Price: $1.31204
Price Difference: ($1.31204 - $1.30998) = $0.00206 = 20.6 points
Profit / Loss: 20.6 points x stake = 20.6 points x £5 per point = £103.00

Better Pricing and Tight Spreads

According to Adam Jepsen, spokesman for http://www.financialspreads.com/ , the new spread betting pricing will allow clients to trade with greater accuracy.

"Spread betting account holders will be trading the same point system as before, however, the quoted price now includes a fraction of a point for greater precision.

"Importantly, our spreads have remained the same and are still among the very tightest in the industry. From Sunday evening all the way through to Friday evening, clients can trade EUR/GBP, EUR/USD and USD/JPY with just 1 point spreads.

"Before trading, please note that spread trading is a leveraged product and therefore carries a high level of risk. Investors can lose more than their initial deposit so you should ensure financial spread betting meets your investment objectives and seek independent financial advice if you do not understand the risks," added Jepsen.

About Financial Spreads

Financial Spreads is based in London and offers live prices on more than 2,500 financial markets. Markets include FX, equities, indices, commodities and treasuries.

The service is commission-free, there are no brokers' fees and clients can trade via www.FinancialSpreads.com and over the phone.

Financial Spreads is a trading name of London Capital Group (LCG) which is authorised and regulated by the Financial Services Authority. LCG is a company registered in England and Wales under registered number: 3218125. Registered address, 2nd Floor, 6 Devonshire Square, London, EC2M 2AB.

Media Contact:
Adam Jepsen
FinancialSpreads.com
020 7456 7061
http://www.financialspreads.com/

PR courtesy of Online PR Media: http://bit.ly/wXCjjM

Dave Ramsey Caught Lying To His Followers, Says Top Gold Pay

Mon, 06 Feb 2012 12:53:19 +0000

/EINPresswire.com/ New book accuses Dave Ramsey of telling a lie that is costing Americans millions, says Brad Gilmore.

Long time gold investor and author, Brad Gilmore, has released a new book entitled, Insider Secrets to Making Money with Gold. In it, he claims that financial guru Dave Ramsey has been lying to his followers about gold in order to make even more money.

"It's a shame that Dave Ramsey is taking advantage of the trust of his listeners. I've seen how this industry works and how the public is not being told the truth and it's time for that to change" stated Gilmore. "People need to know that there are legitimate ways to buy gold at discounted prices and sell it for almost full market value, not like the 40 to 60 percent that these mail in gold companies and pawn shops pay." Gilmore is referring to a company called Gold Stash, which is endorsed by Dave Ramsey on his website and his popular radio show. Gilmore seems to be spilling the beans about the gold industry in his book.

He explains, "These are the things that gold companies don't want you to know about. It's how they make their money at the seller's expense. But this economy is just too rough for people to be getting ripped off. That's why I wrote this book." Gilmore owns a company called Top Gold Pay and offers his groundbreaking book on his website, www.topgoldpay.com . It seems that people have been kept in the dark about what their gold is really worth. Gilmore's book explains everything a person needs to know about buying and selling gold, and he wants everyone to know about it. "This is just the kind of information that America needs right now. It could be the difference between foreclosure, or staying in your home. The big gold companies don't need the money, but hard working Americans do. This book gives them that chance."

Media Contact:
Brad Gilmore
Top Gold Pay
1-800-558-4789
http://www.topgoldpay.com

PR courtesy of Online PR Media: http://bit.ly/zRQUwo

EIN News Announces Launch of China Investment Corp Daily Report

Fri, 03 Feb 2012 08:40:46 +0000

Washington, February 3, 2012 /EINPresswire.com/ EIN News, a leading media monitoring company focused on political, business and industry news, has added China Investment Corp Daily Report to its Company Daily Reports news division.

For more news see:

- China Investment Corp Daily Report - http://chinainvestment.einnews.com/
- Company Daily Reports - http://world.einnews.com/publications/reports

About the publisher of China Investment Corp Daily Report, EIN News (http://www.einnews.com/)

EIN News has developed one of the world's leading real time news indexing services. Its systems continuously scan the web, indexing news from thousands of worldwide sources. The data is then filtered according to specific needs, and the processes are supervised by a team of professional news editors.

Thousands of industry, government and private institutions rely on EIN News for their media monitoring needs. Combining both intelligent search technologies and the human element, EIN News delivers the most efficient, yet personalized media monitoring, news aggregation and syndication services on the market.

EIN News is positioned as the leading news index on the planet.

For more information about EIN News:

David Rothstein
Chief Executive Officer
EIN News (an IPD Group Service)
http://www.einnews.com/contact
http://www.einnews.com

Spread-Betting.org Adds New Spread Betting Comparison Tables

Tue, 31 Jan 2012 15:39:16 +0000

/EINPresswire.com/ The London based financial website Spread-Betting.org, which features a range of reviews, analysis and trading guides, has launched a new set of comparisons tables that compare and contrast a range of spread betting companies.

There is an array of financial spread betting companies that investors can choose from. However, these firms vary in many ways: Does the company offer candlestick charts? Are the markets open 24 hours a day? What kind of trading orders are available?

These are just some of the questions that spread bettors face when looking to sign up with a spread betting company. That is why www.Spread-Betting.org has added a new set of comparison tables.

The comparison tables, launched this month, compare the spreads for some of the most popular financial markets. These include forex pairs such as EUR/USD, GBP/USD, stock market indices such as the FTSE 100 and Dow Jones, and commodities such as gold and crude oil.

"We've seen an increase in the number of traders and investors who are speculating via the derivative of spread betting," said Maxine Price, http://www.spread-betting.org/ editor. "After deciding to spread bet, one of their first questions is often 'where should I trade?'

"There is a large number of spread betting companies to chose from. Naturally, they share a lot of similarities, however there are plenty of variations too.

"A common issue for new spread bettors is whether the company offers a demo account. Whereas more experienced traders are concerned with more technical aspects such as the guaranteed stop orders and 24 hour trading that firms like Financial Spreads offer. Naturally, we address these issues and other aspects such as spread size and minimum stakes."

The spread betting comparison tables also look at factors such as which body regulates the spread betting company, whether credit accounts are available, what trading orders are offered, and more.

"We've been working on adding the new tables for some time now, and we're excited by the result," continued Price. "However, if you're not looking to sign up for a new account, fear not, we still offer news on all the latest market moves, technical analysis and of course our daily spread trading blog."

About Spread-Betting.org

Spread-Betting.org looks at a range of financial markets, and offers analysis on the key global stock markets, commodities markets and forex spread betting markets.

The new comparison tables show whether spread betting companies offer charts, 24 hour trading, stop loss/guaranteed stops, demo accounts and web-based platforms. It also reports on other areas such as which organisation the company is regulated by, what the typical minimum stake is and whether there is a minimum account opening deposit.

Spread betting is a geared product and therefore investors should be aware that it carries a high level of risk. Losses can exceed the initial deposit. Spread betting may not be suitable for all types of investor. Investors should seek independent financial advice where needed and only speculate with funds they can afford to lose.

Media Contact:
Maxine Price
Spread-Betting.org
020 7234 9124
http://www.spread-betting.org/

PR courtesy of Online PR Media: http://bit.ly/yPmAET

Independent Living Bullion's Monthly Investment Program Sees Surge in Sign Ups as Inflation Rises

Fri, 27 Jan 2012 08:14:46 +0000

/EINPresswire.com/ Amid growing concerns about the weakening dollar, precious metals firm recruits 1,250 participants to its innovative monthly automatic silver and gold investment plan.

Independent Living Bullion http://www.independentlivingbullion.com, a company with an A BBB rating, has been overwhelmed with the number of people electing to participate in their automatic monthly gold and silver bullion accumulation plan. As of this month, over 1,250 people and counting have signed up to buy gold monthly (or silver) helping participants save more than $5 million a year in gold and silver on a disciplined monthly basis. With inflation on the rise and the purchasing power of the U.S. dollar decreasing, ILB has seen a jump in the number of investors looking for a safe haven. President of ILB Stefan Gleason believes gold and silver provide the safety investors seek.

But, he doesn't attribute the growth of their program only to inflation and financial turmoil. He believes that people are choosing ILB's automatic monthly plan over others because of its unique design and benefits. "We're absolutely on the cutting edge with our monthly program - making it easy and affordable to switch fiat money into real money."

One of very few in existence and the largest of its kind, ILB's Monthly Silver and Gold Accumulation Plan is a monthly plan to automatically invest in silver and/or gold to increase personal wealth and protection. The minimum is only $150 a month plus there are no entangling contracts. The plan features 67% off shipping and insurance costs, and allows participants to take full advantage of dollar-cost averaging without worrying about timing purchases.

Independent Living Bullion was formed to help savers and investors protect their purchasing power from the inflation and financial turmoil caused by central banks and politicians. The reason for this precious metals dealer's success is simple and straightforward - Independent Living Bullion is secure, private, and offers customers the most gold and silver for their money.

Media Contact:
Stefan Gleason
Independent Living Bullion
1-800-800-1865
http://www.independentlivingbullion.com

PR courtesy of Online PR Media: http://bit.ly/xGu1Wf

Amarantus BioSciences Licenses Disease Diagnostic Biomarker Test from Power3 Medical Products

Mon, 23 Jan 2012 09:16:17 +0000

Amarantus BioSciences Licenses Parkinson's Disease Diagnostic Biomarker Test from Power3 Medical Products

/EINPresswire.com/ SUNNYVALE, CA and THE WOODLANDS, TX - January 23, 2012 - Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing MANF, a first-in-class disease-modifying therapeutic protein being developed for the treatment of Parkinson's Disease, today announced an exclusive worldwide license agreement with Power3 Medical Products, Inc. (OTCBB: PWRM) for the NuroPro(R) Blood Test as it relates to Parkinson's disease diagnosis. Concurrent with the license, Amarantus has raised $100,000 from a private, foreign investor introduced to the Company by www.tomorrowsbluechips.com.

The NuroPro Blood Test is Power3's diagnostic platform for the early detection of neurodegenerative diseases. It is being developed as a tool to assist physicians to more accurately diagnose disease and monitor progression. The platform involves monitoring the concentration of 57 protein markers in blood serum identified to be linked to neurodegeneration in order to accurately detect and distinguish between Alzheimer's disease, ALS (Lou Gehrig's disease), and Parkinson's disease. Amarantus' license is focused on the further development of a subset of 21 of these protein markers specifically targeting early diagnosis and ongoing monitoring of Parkinson's disease.
The Parkinson's disease application of the NuroPro Blood Test has completed proof-of-concept and Phase 1 clinical validation studies. Amarantus plans to initiate a Phase 2 clinical validation study in the first half of 2012 that is expected to last approximately six months. Management of the trial will be partnered to Power3 as part of its ongoing strategy to build its Clinical Research Organization business unit.

"The in-license of the NuroPro Blood Test for Parkinson's disease expands our product offering as we strive to become the leader in the evaluation and treatment of Parkinson's disease," said Gerald Commissioning, President and CEO of Amarantus BioSciences. "Now that we will be able to tailor our therapeutic development pathway towards a companion diagnostic product that we control, Amarantus is positioned to build a strategic advantage over competitors as the execution of our clinical and regulatory strategy continues to advance MANF as a disease-modifying treatment for Parkinson's disease. The Company was also recently awarded the composition of matter patent for MANF by the US Patent & Trademark Office, further enhancing our position in the field."
Given the length of time it takes to accurately diagnose Parkinson's disease and the relatively high early misdiagnosis rates, the development of a blood-based biomarker test is likely to generate significant interest among neurologists and primary care physicians as it will allow them to intervene at an earlier stage in disease progression. In addition, the NuroPro Blood test for Parkinson's may generate partnering and revenue opportunities for Amarantus.
The terms of the agreement give Amarantus an exclusive license to develop, manufacture, have manufactured, use, market, sell and import medical devices and methods under the Power3 Parkinson's Disease Intellectual Property (IP). In addition, the license provides Amarantus an exclusive, royalty-free, fully paid-up worldwide license to Power3 know-how, patents and patent applications which relate to medical devices and methods for the treatment of neurodegenerative disease as it relates to Parkinson's disease.

Amarantus paid a $25,000 exclusivity fee in common stock on November 11, 2011 and will issue to Power3 $475,000 worth of common stock. In addition, Amarantus has an option to purchase all of the Parkinson's Disease IP owned by Power3 for $500,000 worth of common stock and maintains a Right of First Refusal to acquire the balance of the NuroPro platform for Alzheimer's, ALS and all other neurodegenerative diseases. The initial term of this License Agreement is for one year and is renewable upon mutual written agreement of the parties.

About MANF (Mesencephalic-Astrocyte-derived Neurotrophic Factor)
MANF (Mesencephalic-Astrocyte-derived Neurotrophic Factor) is a protein that corrects protein misfolding, one of the major causes of apoptosis (cell death). This property provides a compelling rationale for the research and development of MANF-based products as therapeutics for human disease. The lead MANF product development effort is centered on a therapy for Parkinson's disease, currently funded by a research grant from the Michael J. Fox Foundation for Parkinson's Research. The Company also owns an inventory of 88 cell lines referred to as "PhenoGuard Cell Lines." MANF was the first therapeutic protein discovered from a PhenoGuard Cell Line. It is anticipated that additional therapeutic proteins useful for various therapeutic approaches to the Central Nervous System will be identified from the Company's inventory of PhenoGuard Cell Lines.

About Amarantus BioSciences, Inc.

Amarantus BioSciences, Inc. is a California-based development-stage biotechnology company founded in January 2008. The Company has a focus on developing certain biologics surrounding the intellectual property and proprietary technologies it owns to treat Parkinson's disease and other human diseases. The Company owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF"). For further information please visit www.amarantus.com.

About Power3 Medical Products, Inc.

Power3 Medical Products, Inc. (OTCBB:PWRM) is primarily engaged in commercializing its intellectual properties in the area of diagnosis and treatment of breast cancer, Amyotrophic Lateral Sclerosis (ALS), Alzheimer's disease and Parkinson's disease.

MEDIA CONTACTS:

Lou Levenstein
info@seraphimstrategies.com
727.489.9939

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about the possible benefits of MANF therapeutic applications and/or advantages presented by Amarantus' PhenoGuard technology, as well as statements about expectations, plans and prospects of the development of Amarantus' new product candidates. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including the risks that the anticipated benefits of the therapeutic drug candidates or discovery platforms, as well as the risks, uncertainties and assumptions relating to the development of Amarantus' new product candidates, including those identified under "Risk Factors" in Amarantus' most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q and in other filings Amarantus periodically makes with the SEC. Actual results may differ materially from those contemplated by these forward-looking statements Amarantus does not undertake to update any of these forward-looking statements to reflect a change in its views or events or circumstances that occur after the date of this presentation.

Amarantus BioSciences Interview at the 2012 Biotech Showcase

Fri, 20 Jan 2012 10:28:00 +0000

/EINPresswire.com/ SUNNYVALE, CA - January 20, 2012 - Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing MANF, a first-in-class disease-modifying therapeutic protein, was interviewed at the 2012 Biotech Showcase in San Francisco last week. The interview can be accessed via the following link: http://stocknewsnow.com/?p=2825.

About Amarantus BioSciences, Inc.

Amarantus BioSciences, Inc. is a California-based development-stage biotechnology company founded in January 2008. The Company has a focus on developing certain biologics surrounding the intellectual property and proprietary technologies it owns to treat Parkinson's disease and other human diseases. The Company owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF"). For further information please visit www.amarantus.com.

MEDIA CONTACT:

Lou Levenstein
727.489.9939
info@seraphimstrategies.com

Amarantus BioSciences to be Interviewed on The Big Biz Radio Show

Thu, 12 Jan 2012 22:21:07 +0000

/EINPresswire.com/SUNNYVALE, CA - January 12, 2012 - Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing MANF, a first-in-class disease-modifying therapeutic protein, today announced the company will be a featured guest on The Big Biz Radio Show on Friday, January 13, 2012 at 1:10 PM PDT. The live broadcast can be accessed via the show's website: http://bigbizshow.com/media/
The Big Biz Show is a nationwide radio broadcast featuring commentators Bob Sullivan and Russ Nailz who discuss topics including current events, business trends, investment opportunities, innovations in headline making industries, and hot stock picks.

About Amarantus BioSciences, Inc.

Amarantus BioSciences, Inc. is a California-based development-stage biotechnology company founded in January 2008. The Company has a focus on developing certain biologics surrounding the intellectual property and proprietary technologies it owns to treat Parkinson's disease and other human diseases. The Company owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF"). For further information please visit www.amarantus.com.

Contact:
Lou Levenstein
727-489-9939
info@seraphimstrategies.com
www.tomorrowsbluechips.com

Amarantus BioSciences Releases New Video Interview with President and CEO Gerald Commissiong

Fri, 06 Jan 2012 10:55:18 +0000

/EINPresswire.com/ Amarantus BioSciences Inc. (OTCBB: AMBS) is a biopharmaceutical company that has discovered a revolutionary therapeutic protein that could change the way many major diseases are treated. Recently, the biotech company released a video interview with its CEO, Gerald Commissiong that covers its development of MANF. Unlike Insmed Inc. (NASDAQ:INSM) or Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), MANF works by reversing the properties of cell apoptosis, which has shown strong signs of efficacy in a wide range of conditions. Recently, the company updated shareholders on its expanded corporate strategy and execution.

Amarantus BioSciences, Inc. released news on January 3, 2012 providing shareholders with an update on the execution of its expanded corporate strategy first announced on November 1st 2011 to position Amarantus as a neurology-focused biotechnology company. Since that time, the Company has:
Received grant funding for a Traumatic Brain Injury collaboration with Banyan Biomarkers from Brewer Sports International;
Recruited seasoned neurology executive Mark Benedyk, PhD to advise the company on strategy and business development efforts;
Received positive feedback on the Company's updated business plan from investors who attended the Company's presentation at the National Investment Banking Association conference in Las Vegas, NV on December 1st, 2011.

"Amarantus has made good progress since the announcement of the Company's expanded corporate strategy, and management will work diligently to cause this trend will continue into 2012," said Gerald Commissiong, Amarantus' newly appointed President and CEO. "We will continue to focus our efforts on securing additional corporate partnerships, improving our pipeline and adding seasoned neurology-focused executives to the executive team in order to diligently build shareholder value and improve the standard of care for patients."
Amarantus believes that it has a unique opportunity to effect meaningful improvements in the treatment of Parkinson's disease for millions of patients worldwide. The Company expects to release additional results to the marketplace from its lead program for Parkinson's disease in the first half of 2012.

About MANF (Mesencephalic-Astrocyte-derived Neurotrophic Factor)
MANF (Mesencephalic-Astrocyte-derived Neurotrophic Factor) is a protein that corrects protein misfolding, one of the major causes of apoptosis (cell death). This property provides a compelling rationale for the research and development of MANF-based products as therapeutics for human disease. The lead MANF product development effort is centered on a therapy for Parkinson's disease, currently funded by a research grant from the Michael J. Fox Foundation for Parkinson's Research. The Company also owns an inventory of 88 cell lines referred to as "PhenoGuard Cell Lines." MANF was the first therapeutic protein discovered from a PhenoGuard Cell Line. It is anticipated that additional therapeutic proteins useful for various therapeutic approaches to the Central Nervous System will be identified from the Company's inventory of PhenoGuard Cell Lines.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about the possible benefits of MANF therapeutic applications and/or advantages presented by Amarantus' PhenoGuard technology, as well as statements about expectations, plans and prospects of the development of Amarantus' new product candidates. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including the risks that the anticipated benefits of the therapeutic drug candidates or discovery platforms, as well as the risks, uncertainties and assumptions relating to the development of Amarantus' new product candidates, including those identified under "Risk Factors" in Amarantus' most recently filed Annual Report on Form 10-K and Quarterly Report on Form 10-Q and in other filings Amarantus periodically makes with the SEC. Actual results may differ materially from those contemplated by these forward-looking statements Amarantus does not undertake to update any of these forward-looking statements to reflect a change in its views or events or circumstances that occur after the date of this presentation.

Investor Relations Contact:

Seraphim strategies

Lou Levenstein

www.seraphimstrategies.com
www.tomorrowsbluechips.com
727-489-9939

2012 Stock Market Investing Tips In Penny Stocks Breaking News Report by Blaque Capital Stocks

Wed, 04 Jan 2012 09:50:50 +0000

/EINPresswire.com/ The Report Below Lists Stocks That May Be The Hottest in the New Year By www.blaquecapitalstocks.com The Best Penny Stock Newsletter Recommended by Online Traders for NASDAQ, AMEX, NYSE, OTCBB & Pink Sheets Stock Picks.

Investors are eagerly awaiting the Facebook IPO , Raystream Inc. (RAYS) continues to be on investor radars , American Airlines - AMR Corporation (AMR) currently a penny stock may soon be delisted by the NYSE. North Springs Resources Corp (NSRS.OB) could be the hottest stock pick in January, global investors can receive the full report here.

Warren Buffet said, "The time to get interested is when no one else is. Investors can't buy what is popular and do well."

Hot stock reports delivered via email to readers on some of the most exciting small cap companies trading on the OTC BB and Pink Sheet Market. Online stock trading alerts periodically profiled on emerging growth companies that could become the next big thing. Subscribe today to get hot stock tips from Blaque Capital Stocks.

About [Blaque Capital Stocks]
Disclosure: Blaque Capital Stocks is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Blaque Capital Stocks is a wholly owned entity of a financial public relations firm. Please read our report and visit our website, for complete risks and disclosures.

Media Contact:
Ben Evans
Blaque Capital Stocks
9092280295
http://blaquecapitalstocks.com

PR courtesy of Online PR Media: http://bit.ly/AnssgK

Will United Nations Angel dawn World Peace?

Tue, 20 Dec 2011 07:28:13 +0000

/EINPresswire.com/ December 20th, 2011 Chauvet Cave, France

A Pegasus has just been unveiled at the UNESCO Chauvet Cave in Southern France. The profound symbolism was explained by metaphysical scholars Gerald D'Aoust and Daryl Breese. The Pegasus has always been a symbol of the Holy Spirit and Peace. Four angelic encounters led the team to this cave art, now the oldest religious relic which has pushed back the dawn of religion another 15,000 years.
The Pegasus is showcased in two murals. One graphic is the first Story of Creation and the other shows animals getting off a vessel which has landed on a mountain. Enjoy this treasure of graphics, linked below. Breese posted exhaustive details of interpretation 'on line' for the world to enjoy!
http://www.culture.gouv.fr/culture/arcnat/chauvet/en/owpt14.htm
www.culture.gouv.fr/culture/arcnat/chauvet/en/owpt24.htm
http://www.culture.gouv.fr/culture/arcnat/chauvet/img/fond0421.jpg
D'Aoust and Breese just published the non-fiction "God's Steed- Key to World Peace" (Lulu 2011). The Chauvet Pegasus is featured on the book's cover. Like Tom Hanks in the fictional "Angels and Demons", they are the real life 'symbologists' who have discovered this ancient point from which all religion and philosophy have descended- and will culminate. "Cave of Forgotten Dreams" by Werner Herzog lets us see this earliest cave art. Some viewers report visions after seeing the movie.
Breese believes the common ground of this new discovery connects all the Holy Books and could spawn greater understanding, tolerance and harmony. Will this usher in the Age of Aquarius?

Sir Knight Daryl Breese
Nampa, Idaho USA
calbreese@hotmail.com
(661)703-4444

Online-Spread-Betting.com Adds a New Review of FinancialSpreads.com

Wed, 14 Dec 2011 22:13:16 +0000

Financial news source and review site, Online-Spread-Betting, has added a brand new review of FinancialSpreads.com

/EINPresswire.com/Financial news source and review site, Online-Spread-Betting, has added a brand new review of FinancialSpreads.com. This latest update adds to the array of spread betting company reviews that the site already offers.

Spread betting has seen a huge increase in popularity in recent years. The increase in the number of traders and investors choosing the derivative can be put down to a range of factors.

Some will cite the fact that spread betting is tax free*, with no stamp duty, no capital gains tax and no income tax. Others will say that it is due to the range of markets that are available, while others may argue that it's due to the flexibility of the derivative; speculators can often spread bet online, over the phone and on smartphones.

However, regardless of the reason, spread betting is certainly becoming more popular. And with that increase in popularity comes a growing number of spread betting companies.

Many of the firms and services differ but one of the most notable differences can be the size of the 'spread' itself. With financial spread betting there are no commissions or brokers' fees and so the size, or width, of the spread becomes increasingly important to investors. This is because whether an investor wins or loses on a trade the width of the spread is seen as one of the main trading costs.

There are other differentiating features though such as whether a firm offers charts, stop losses, demo accounts and 24 hour spread betting.

This is why the financial website www.Online-Spread-Betting.com has been releasing a series of spread betting reviews. The latest one, released this week, looks at FinancialSpreads.com.

Emma Franklin, Editor at http://www.online-spread-betting.com/, says that company reviews have been launched in response to the increasing popularity of the derivative.

"The growth of spread betting has meant that there are now a range of spread betting companies. Some of these companies offer tighter spreads than others, and the range of markets that are available differs too," she said.

"That is why we've launched this latest guide, to help spread bettors decide on which spread trading company is right for them."

The review offers a general overview of the company and assesses which markets the company offers. To add to this, it also takes a detailed look at what services the company offers, including trading charts, stops losses/guaranteed stop losses, demo accounts and 24 hour trading.

About Online-Spread-Betting.com

Online-Spread-Betting is a trading website that offers a range of services for spread bettors, including daily market analysis, financial spread betting prices, daily spread betting tips, regular trading news and technical analysis.

http://www.financialspreads.com/ is a spread betting company that offers over 2,500 markets, trading charts, 24 hour spread betting, stop losses, guaranteed stop losses and demo accounts. FinancialSpreads.com is a trading name of London Capital Group which is regulated and authorised by the Financial Services Authority.

Financial spread betting is a geared investment product which carries a high degree of risk and investors can lose more than their initial stake or deposit.

Investors should only speculate with capital that they can afford to lose and before spread betting they should make sure that they are familiar with the risks involved and seek independent financial advice where necessary.

* As per current UK tax law, this may differ or change depending upon personal circumstances.

Media Contact:
Emma Franklin
Online-Spread-Betting.com
++44 (0) 20 7234 912
http://www.online-spread-betting.com/

PR courtesy of Online PR Media: http://bit.ly/sdlmEl

Clean Financial Add a New Financial Spread Betting Company Review Section

Wed, 14 Dec 2011 22:12:24 +0000

/EINPresswire.com/The spread betting website www.CleanFinancial.com has launched a brand new section as part of on-going improvements to the site

The new spread betting company review section, which the site has been working on for over 3 months, reviews a range of spread betting companies.

"We've been working on the new section for 3 months," said Jenna Cutly, editor at Clean Financial. "There are a range of spread betting companies that offer traders and investors the opportunity to speculate on the financial markets.

"Some of them are similar, however many of the products and services differ, which is why we've introduced this comprehensive new review. We want to help spread bettors identify these differences."

The section, launched this month, covers a wide range of areas, and opens with a price review comparing over 25 spread betting markets. In spread betting a primary cost for investors is the width of the 'spread'. Therefore the price comparison reviews the spread sizes for the most popular markets including stock market indices such as the FTSE 100 and Wall St, forex markets such as GBP/USD and EUR/GBP and commodities such as gold and oil. It also covers both daily and futures markets.

Spread bettors who are interested in specific firms can drill down and look at more specific areas. This includes details such as whether the company offers CFD trading, mobile trading platforms, price alerts (which alert a spread bettor when markets hit certain levels) as well as what types of trading order are available.

Charting packages are also reviewed; the new section not only looks at which companies offer charts/analysis, but also what types of analysis users can quickly glean from the charts.

"We've been working on this section for a long time," continued Cutly. "We understand that, with the current economic crisis continuing to trouble traders, spread bettors are looking for the products and services that suit their trading strategy. Our aim is to help them find it."

The new section is available now, for more information, see http://www.CleanFinancial.com/.

About Clean Financial

Clean Financial is a spread betting website which brings investors the latest movements in the financial markets. It accommodates both the novice investor and the advanced trader alike, with daily analysis, market reviews, daily spread betting tips, trading guides and more.

The new section looks at a number of companies such as Financial Spreads as well as a number of markets, including indices, commodities, forex, bonds and shares spread betting markets.

Investors should note that financial spread betting is a leveraged financial product, it involves a high degree of risk and it is possible to incur losses that exceed their initial investment. Anyone investing through leveraged products should only trade with capital that they can afford to lose.

Before spread betting, investors should ensure that this form of trading matches their investment objectives, make sure they familiarise themselves with the risks and, where required, request independent financial advice.

Media Contact:
Jenna Cutly
CleanFinancial.com
020 7234 9124
http://www.cleanfinancial.com/

PR courtesy of Online PR Media: http://bit.ly/vQYlX1

Entrepreneurs Can Now Approach Angel Investors Easily With New Networking Tool

Tue, 13 Dec 2011 13:11:52 +0000

/EINPresswire.com/ www.McKenson-Invest.com is a professional online networking site that connects investors looking for new investment opportunities with entrepreneurs seeking funding.

The role of McKenson-Invest.com is to facilitate contacts between investors and entrepreneurs. The platform provides subscribers with free access to its presentation sheets on display.

After clicking on the button for the sign-up page, users register by mentioning their own email address and password. Then they complete the fields in the profile pages in order to appear later in the search results of others members: they describe their product or service, select the sector and the country where the project is located and indicate the amount of funding. Thereafter, entrepreneurs and investors can submit projects online.

The visitors, once connected to their personal space on the website, have the ability to send or receive emails and chat with subscribers who express an interest in their project. They can preserve the history of the messages exchanged. The usefulness of using a pseudonym generated by a random process instead of the real name in the profiles resides in the ability to maintain complete anonymity during the navigation. The site, which exists in English, French and Spanish, allows users to view online business plans and investment projects, where all the important information is accessible thanks to a search tool that filters the results by country, sector or keyword.

Against a background of international financial crisis, McKenson Invest offers entrepreneurs the opportunity to approach angel investors easily and it is a great way for private investors to turn to emerging countries in order to find projects with high potential.

New information posted on the website is thoroughly moderated to guarantee the confidentiality of the data, according to the proposed conditions of use.

About McKenson Invest:

Launched in July 2009, McKenson-Invest.com is an online networking service that connects entrepreneurs with investors. Visitors must register before using the site, after which they describe the business plan or investment project. Additionally, they can save other contacts as favorites and exchange messages, including automatic notifications when they send emails. Founded by Harley McKenson, the website was initially dedicated to Africa, a continent which becomes a more attractive place to invest than it was before.

Media Contact:
Harley McKenson
McKenson Invest
33134509283
http://www.McKenson-Invest.com

PR courtesy of Online PR Media: http://bit.ly/sKWNVZ